PMID: 11907009Mar 22, 2002Paper

Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia

Heart
A O HausseP Rustin

Abstract

Friedreich's ataxia encodes a protein of unknown function, frataxin. The loss of frataxin is caused by a large GAA trinucleotide expansion in the first intron of the gene, resulting in deficiency of a Krebs cycle enzyme, aconitase, and of three mitochondrial respiratory chain complexes (I-III). This causes oxidative stress. Idebenone, a short chain quinone acting as an antioxidant, has been shown to protect heart muscle against oxidative stress in some patients. To assess the efficiency of idebenone on cardiac hypertrophy in Friedreich's ataxia. Prospective, open trial. Tertiary care centre. Idebenone (5 mg/kg/day) was given orally to 38 patients with Friedreich's ataxia aged 4-22 years (20 males, 18 females). Cardiac ultrasound indices were recorded before and after idebenone treatment. After six months, cardiac ultrasound indicated a reduction in left ventricular mass of more than 20% in about half the patients (p < 0.001). The shortening fraction was initially reduced in six of the 38 patients (by between 11-26%) and it improved in five of these. In one patient, the shortening fraction only responded to 10 mg/kg/day of idebenone. No correlation was found between responsiveness to idebenone and age, sex, initial ultrasound in...Continue Reading

References

Jul 21, 1988·Nature·S ChamberlainR Williamson
Jun 1, 1988·British Heart Journal·B PalagiM Morpurgo
Jan 15, 1981·The New England Journal of Medicine·A W Nienhuis
Apr 15, 1996·The American Journal of Cardiology·F Casazza, M Morpurgo
Oct 17, 1996·The New England Journal of Medicine·A DürrM Koenig
Jul 17, 1998·Annals of Neurology·R B WilsonK H Fischbeck
Oct 16, 1999·Archives of Neurology·M Pandolfo
Jan 14, 2000·Journal of Medical Genetics·M B DelatyckiS M Forrest
Dec 13, 2000·Neurology·J B SchulzM B Bogdanov

❮ Previous
Next ❯

Citations

Apr 1, 2003·Annals of Neurology·M Flint Beal
Dec 30, 2003·BioFactors·J M Cooper, A H V Schapira
Jan 7, 2009·European Journal of Clinical Pharmacology·Michael BodmerJürgen Drewe
Aug 22, 2008·Pediatric Cardiology·Alaina KippsElizabeth D Blume
Apr 11, 2009·Journal of Neurology·Thomas Meier, Gunnar Buyse
Apr 11, 2009·Journal of Neurology·Klaus KutzPierre Vankan
Apr 11, 2009·Journal of Neurology·Jörg B SchulzKenneth Fischbeck
Jun 21, 2008·Neuromolecular Medicine·P Hemachandra Reddy
Sep 25, 2010·The Cerebellum·Daniel Velasco-SánchezMercedes Pineda
Feb 23, 2013·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Orest Hurko
May 18, 2005·Journal of the Neurological Sciences·Vittorio CalabreseD Allan Butterfield
Mar 5, 2003·Journal of the Neurological Sciences·Robert B Wilson
Oct 3, 2002·Molecular Genetics and Metabolism·Vanna GeromelPierre Rustin
Jun 18, 2002·Trends in Molecular Medicine·Agnès RötigPierre Rustin
Feb 8, 2008·Nature Clinical Practice. Neurology·Massimo Pandolfo
Apr 7, 2009·Nature Reviews. Neurology·Jörg B SchulzMassimo Pandolfo
Jan 20, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Silvia Gomez-SebastianRichard Wade-Martins
Dec 1, 2006·The Cerebellum·Susan MichaelArnulf H Koeppen
May 9, 2006·Antioxidants & Redox Signaling·Raffaele LodiAnthony H V Schapira
Dec 4, 2008·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J M CooperA H V Schapira
Apr 10, 2007·Annual Review of Neuroscience·Harry T Orr, Huda Y Zoghbi
Oct 18, 2007·Acta Haematologica·Maya Otto-DuesselJohn C Wood
Aug 4, 2012·Journal of Child Neurology·Claire N AshleyBernard L Maria
Jul 14, 2012·Journal of Child Neurology·Robert B Wilson
Oct 12, 2011·BMC Medicine·Aurélien BayotPierre Rustin
Jan 30, 2010·PloS One·Pilar Gonzalez-CaboFrancesc Palau
Dec 8, 2009·Neuropsychiatric Disease and Treatment·Meredith SpindlerClaire Henchcliffe
Mar 27, 2009·CNS Drugs·Amy Y TsouDavid R Lynch
Aug 24, 2011·World Journal of Cardiology·Nipon ChattipakornSiriporn Chattipakorn
Nov 14, 2013·The Cerebellum·W IlgD Timmann
Jul 19, 2003·Current Opinion in Neurology·Roger L Albin
Oct 3, 2003·Expert Opinion on Pharmacotherapy·Susan L Perlman
Oct 2, 2003·Expert Opinion on Investigational Drugs·Steven K Baker, Mark A Tarnopolsky
Apr 1, 2003·Expert Opinion on Investigational Drugs·Pierre Rustin
Aug 20, 2008·Expert Opinion on Pharmacotherapy·Caterina Tonon, Raffaele Lodi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.